RPHM
RPHM Real Time Price USDRecent trades of RPHM by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by RPHM's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
RPHM Revenue by Segment or Geography
New patents grants
-
Patent Title: Use of ppar-delta agonists in the treatment of disease Mar. 19, 2024
-
Patent Title: Crystalline pparδ agonist Aug. 01, 2023
-
Patent Title: Crystalline ppar-delta agonist Mar. 08, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to RPHM
Number of mentions of RPHM in WallStreetBets Daily Discussion
Recent picks made for RPHM stock on CNBC
ETFs with the largest estimated holdings in RPHM
|
Shareholder
|
Shares Held
|
|---|
- Who owns $RPHM stock?
- Who owns the most shares of $RPHM stock?
- What funds own $RPHM stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RPHM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.